Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Hasson Heather L. | FIGS FIGS, Inc. | 13D/A | 9.49% | Oct 26, 2023 | 3y |
| IMA Value LLP | RAVE Rave Restaurant Group, Inc. | 13D | 5.33% | Oct 23, 2023 | 3y |
| White Lion Capital, LLC | ACON Aclarion, Inc. | 13G | 5.9% | Oct 23, 2023 | 3y |
| Deep Track Capital, LP | ABVX Abivax S.A. | 13G | 6.14% | Oct 20, 2023 | 3y |
| RA CAPITAL MANAGEMENT, L.P. | MGNX Macrogenics Inc | 13G | 6.1% | Oct 20, 2023 | 3y |
| ELLINGTON MANAGEMENT GROUP LLC | RPT Rithm Property Trust Inc. | 13G | 7.1% | Oct 20, 2023 | 3y |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ARQT Arcutis Biotherapeutics, Inc. | 13G | 9.99% | Oct 20, 2023 | 3y |
| HCG Opportunity, LLC | CDAQF Compass Digital Acquisition Corp. | 13D | 36.4% | Oct 19, 2023 | 3y |
| Qiming U.S. Healthcare Fund II, L.P. | TRML Tourmaline Bio, Inc. Common Stock | 13D/A | 3.2% | Oct 19, 2023 | 3y |
| Perception Capital Partners II LLC | SPEC Spectaire Holdings, Inc. Common Stock | 13D | 59.6% | Oct 19, 2023 | 3y |
| Paradigm Biocapital Advisors LP | NUVL Nuvalent, Inc. | 13G | 5.9% | Oct 19, 2023 | 3y |
| MOORE CAPITAL MANAGEMENT, LP | EGOX Next.e.GO N.V. Ordinary Shares | 13G | 9.3% | Oct 19, 2023 | 3y |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ETNB 89bio, Inc. Common Stock | 13G | 6.4% | Oct 18, 2023 | 3y |
| Capital World Investors | VNTR Venator Materials PLC | 13D | 18% | Oct 12, 2023 | 3y |
| Eureka Therapeutics, Inc. | ESLA Estrella Immunopharma, Inc. | 13D | 71.8% | Sep 29, 2023 | 3y |
| Dan Wilks | DWSN Dawson Geophysical Co | 13D/A | 80.03% | Sep 19, 2023 | 3y |
| Mark E. Strome | ZIVO Zivo Bioscience, Inc. | 13D/A | 5.3% | Jun 2, 2021 | 3y |
| Rithm Capital Corp. | SCU Sculptor Capital Management, Inc. Class A Common Stock | 13D/A | 12.8% | Oct 26, 2023 | 3y |
| Harraden Circle Investments, LLC | ACBA Ace Global Business Acquisition Limited Ordinary Shares | 13G | 5.25% | Oct 25, 2023 | 3y |
| Murchinson Ltd. | NNDM Nano Dimension Ltd. | 13D/A | 6.6% | Oct 25, 2023 | 3y |
| Steamboat Capital Partners, LLC | WHLR Wheeler Real Estate Investment Trust, Inc. | 13D/A | 9.2% | Oct 25, 2023 | 3y |
| Sherborne Investors Management LP | NAVI Navient Holdings, Inc. | 13D/A | 25% | Oct 25, 2023 | 3y |
| FJ Capital Management LLC | BANC Banc Of California, Inc. | 13G | 5.02% | Oct 25, 2023 | 3y |
| Brookfield Oaktree Holdings, LLC | GTX Garrett Motion Inc. | 13D/A | 13.9% | Oct 24, 2023 | 3y |
| Trevor Bezdek | GDRX GoodRx Holdings, Inc. | 13D/A | 5.5% | Oct 22, 2023 | 3y |
| Douglas Joseph Hirsch | GDRX GoodRx Holdings, Inc. | 13D/A | 5.5% | Oct 22, 2023 | 3y |
| Deep Track Capital, LP | TRML Tourmaline Bio, Inc. Common Stock | 13G | 8.93% | Oct 20, 2023 | 3y |
| John Michael DiMaio | MDAI Spectral AI, Inc. | 13D | 17.1% | Oct 20, 2023 | 3y |
| Steamboat Capital Partners, LLC | WHLR Wheeler Real Estate Investment Trust, Inc. | 13D/A | 1.3% | Oct 19, 2023 | 3y |
| Pfizer Inc | TRML Tourmaline Bio, Inc. Common Stock | 13G | 6.26% | Oct 19, 2023 | 3y |
| Commodore Capital LP | NKTX Nkarta, Inc. | 13G | 5.6% | Oct 19, 2023 | 3y |
| GLAZER CAPITAL, LLC | HCCI Heritage-Crystal Clean, Inc. | 13G/A | 0% | Oct 17, 2023 | 3y |
| 272 Capital LP | SQNS Sequans Communications | 13D/A | 18.5% | Sep 26, 2023 | 3y |
| Quogue Capital LLC | IOVA Iovance Biotherapeutics, Inc. | 13D/A | 15.84% | Sep 15, 2023 | 3y |
| Cleveland Avenue Food and Beverage Fund II, LP | PRST Presto Technologies, Inc. Common Stock | 13D | 17.3% | Sep 21, 2022 | 3y |
| CWAM LC Sponsor LLC | LCW Learn CW Investment Corporation Class A Ordinary Shares | 13D/A | 42.8% | Oct 13, 2021 | 3y |
| SIT INVESTMENT ASSOCIATES INC | CLM Cornerstone Strategic Investment Fund, Inc. | 13G/A | 4.68% | Oct 26, 2023 | 3y |
| Galloway Capital Partners, LLC | WYY Widepoint Corp | 13D | 4.31% | Oct 26, 2023 | 3y |
| Lux Donn S. | CASK Sempreon, Inc | 13D/A | 36.2% | Oct 25, 2023 | 3y |
| Silver Lake West HoldCo, L.P. | EDR Endeavor Group Holdings, Inc. | 13D/A | 45.1% | Oct 25, 2023 | 3y |
| Pershing Square Capital Management, L.P. | HHH Howard Hughes Holdings Inc. | 13D/A | 34.9% | Oct 24, 2023 | 3y |
| Frazier Life Sciences VIII, L.P. | ARQT Arcutis Biotherapeutics, Inc. | 13D/A | 9.4% | Oct 24, 2023 | 3y |
| Ben M. Brigham | AESI Atlas Energy Solutions Inc. | 13D/A | 45.1% | Oct 24, 2023 | 3y |
| Castle Creek Capital Partners VIII, LP | BWB Bridgewater Bancshares Inc | 13D/A | 7.9% | Oct 24, 2023 | 3y |
| Erich Spangenberg | MDAI Spectral AI, Inc. | 13D/A | 32.68% | Oct 20, 2023 | 3y |
| Braden Ferrari | BTLN Brightline Interactive, Inc. | 13G/A | 5.67% | Oct 20, 2023 | 3y |
| MILLENNIUM MANAGEMENT LLC | MRVI Maravai Lifesciences Holdings, Inc. | 13G | 5.3% | Oct 20, 2023 | 3y |
| Deerfield Management Company, L.P. | NKTX Nkarta, Inc. | 13G | 6.93% | Oct 17, 2023 | 3y |
| Anson Funds Management LP | VIEW View, Inc. Class A Common Stock | 13D | 2.2% | Oct 16, 2023 | 3y |
| FR Capital Holdings, L.P. | NTBL Notable Labs, Ltd. Ordinary Shares | 13G | 11.6% | Oct 16, 2023 | 3y |